Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,445,471
+$5,185,882 QoQ
Shares Held
199,265
+85.8% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#104
of 1,033 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Derivatives in GSK
reported options exposure · as of Jun 30, 2024CallValue
$13,860,000
CallShares
360,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $100,420,553 across 10 Drug Manufacturers - General names. GSK ranks #3 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
240,327 | $48,495,411 | |
| 2 | ABBV |
AbbVie Inc.
|
104,287 | $26,242,780 | |
| 3 | GSK |
GSK plc
This page
|
199,265 | $10,445,471 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
57,030 | $7,205,170 | |
| 5 | NVS |
Novartis AG
|
16,468 | $2,580,864 | |
| 6 | MRK |
Merck & Co., Inc.
|
15,528 | $1,995,348 | |
| 7 | JNJ |
Johnson & Johnson
|
6,461 | $1,640,900 | |
| 8 | SNY |
Sanofi
|
15,897 | $678,166 |
All Filings in GSK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,445,471 | 199,265 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $5,259,589 | 107,251 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $15,102,460 | 349,918 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,773,043 | 593,048 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $31,244,081 | 806,507 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $75,656,489 | 2,237,034 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $54,369,010 | 1,329,966 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,120,155 | 81,043 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $13,860,000 | 360,000 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $26,165,190 | 610,338 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $25,271,214 | 681,900 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $18,436,822 | 508,602 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $23,572,260 | 661,399 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,860,201 | 333,339 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,754,498 | 249,132 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,267,507 | 314,900 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $7,269,215 | 170,145 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $11,178,766 | 258,449 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,536,945 | 147,745 | Shares | Sole | 2021-11-16 | |
| 2020-06-30 | $2,110,120 | 52,744 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,007,773 | 27,118 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||